Aims: Among the putative mechanisms proposed to be common factors in Down syndrome (DS) and Alz- heimer’s disease (AD) neuropathology, deficits in protein quality control (PQC) have emerged as a unifying mechanism of neurodegeneration. Considering that disturbance of protein degradation systems is present in DS and that oxidized/misfolded proteins require polyubiquitinylation for degradation via the ubiquitin pro- teasome system, this study investigated if dysregulation of protein polyubiquitinylation is associated with AD neurodegeneration in DS. Results: Postmortem brains from DS cases before and after development of AD neuropathology and age-matched controls were analyzed. By selectively isolating polyubiquitinated proteins, we were able to identify specific proteins with an altered pattern of polyubiquitinylation as a function of age. Interestingly, we found that oxidation is coupled with polyubiquitinylation for most proteins mainly involved in PQC and energy metabolism. Innovation: This is the first study showing alteration of the polyubiquitinylation profile as a function of aging in DS brain compared with healthy controls. Understanding the onset of the altered ubiquitome profile in DS brain may contribute to identification of key molecular regulators of age-associated cognitive decline. Conclusions: Disturbance of the polyubiquitinylation ma- chinery may be a key feature of aging and neurodegeneration. In DS, age-associated deficits of the proteolytic system may further exacerbate the accumulation of oxidized/misfolded/polyubiquitinated proteins, which is not efficiently degraded and may become harmful to neurons and contribute to AD neuropathology.

Polyubiquitinylation profile in down syndrome brain before and after the development of Alzheimer neuropathology / Tramutola, Antonella; DI DOMENICO, Fabio; Barone, Eugenio; Arena, Andrea; Giorgi, Alessandra; DI FRANCESCO, Laura; Schinina', Maria Eugenia; Coccia, Raffaella; Head, Elizabeth; Butterfield, D. Allan; Perluigi, Marzia. - In: ANTIOXIDANTS & REDOX SIGNALING. - ISSN 1523-0864. - 26:7(2017), pp. 280-298. [10.1089/ars.2016.6686]

Polyubiquitinylation profile in down syndrome brain before and after the development of Alzheimer neuropathology

TRAMUTOLA, ANTONELLA;DI DOMENICO, FABIO;BARONE, EUGENIO;ARENA, ANDREA;GIORGI, ALESSANDRA;DI FRANCESCO, LAURA;SCHININA', Maria Eugenia;COCCIA, Raffaella;PERLUIGI, Marzia
2017

Abstract

Aims: Among the putative mechanisms proposed to be common factors in Down syndrome (DS) and Alz- heimer’s disease (AD) neuropathology, deficits in protein quality control (PQC) have emerged as a unifying mechanism of neurodegeneration. Considering that disturbance of protein degradation systems is present in DS and that oxidized/misfolded proteins require polyubiquitinylation for degradation via the ubiquitin pro- teasome system, this study investigated if dysregulation of protein polyubiquitinylation is associated with AD neurodegeneration in DS. Results: Postmortem brains from DS cases before and after development of AD neuropathology and age-matched controls were analyzed. By selectively isolating polyubiquitinated proteins, we were able to identify specific proteins with an altered pattern of polyubiquitinylation as a function of age. Interestingly, we found that oxidation is coupled with polyubiquitinylation for most proteins mainly involved in PQC and energy metabolism. Innovation: This is the first study showing alteration of the polyubiquitinylation profile as a function of aging in DS brain compared with healthy controls. Understanding the onset of the altered ubiquitome profile in DS brain may contribute to identification of key molecular regulators of age-associated cognitive decline. Conclusions: Disturbance of the polyubiquitinylation ma- chinery may be a key feature of aging and neurodegeneration. In DS, age-associated deficits of the proteolytic system may further exacerbate the accumulation of oxidized/misfolded/polyubiquitinated proteins, which is not efficiently degraded and may become harmful to neurons and contribute to AD neuropathology.
File allegati a questo prodotto
File Dimensione Formato  
Tramutola_Polyubiquitinylation_2017.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 947.93 kB
Formato Adobe PDF
947.93 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11573/935436
Citazioni
  • ???jsp.display-item.citation.pmc??? 19
  • Scopus 30
  • ???jsp.display-item.citation.isi??? 28
social impact